InvestorsHub Logo
Followers 70
Posts 15576
Boards Moderated 2
Alias Born 05/14/2010

Re: None

Monday, 09/29/2014 10:11:11 PM

Monday, September 29, 2014 10:11:11 PM

Post# of 126111
Ok in all fairness I did a little DD on Viveve Medical, Inc., PLCSD. So my guess was correct, Capital Change=shs decreased by 1 for 100 split. Ex-date=09/25/2014.

Now I'm sure some of you have seen ads for penis enlargement... But vaginal tightening? They may be on to something, lol...

Business Description
Viveve, Inc. is a women's health company passionately committed to advancing new solutions to improve women's overall well-being and quality of life. The company's lead product, the Viveve System, is a non-surgical, non-ablative medical device that remodels collagen and restores tissue. The Viveve System treats the condition of vaginal laxity, which is the result of the over-stretching of tissue during childbirth, which can result in a decrease in sexual function and physical sensation. Physician surveys indicate that vaginal laxity is the number one post-delivery physical change for women, being more prevalent than weight gain, urinary incontinence or stretch marks. The Viveve Treatment uses patented, reverse-thermal gradient radiofrequency technology to tighten the tissues of the vaginal introitus (opening) and requires only a 30-minute out-patient treatment in a physician's office. The Viveve System has received regulatory approval in Europe, Canada and Hong Kong and is available through physician import license in Japan. The company is currently working on receiving a 510K indication in the U.S.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.